Abstract
Interleukin 15 (IL-15) is a 14–15 kDa polypeptide that belongs to the 4 α-helix-bundle family of cytokines and was originally discovered due to its T cell proliferative activity. It utilizes the signal-transducing β/γ polypeptides of the IL-2 receptor complex, thus sharing many biological activities with IL-2, in addition to its high-affinity private receptor subunit IL-15Rα. Accumulating evidence indicates that the biological relevance of IL-15 may not solely be confined to T lymphocytes, but to a variety of cell populations within the immune system as well as outside the immune system of the host. The expression of both IL-15 and its high-affinity receptor component, IL-15Rα, are readily demonstrable in a wide variety of tissues and appear to be augmented in response to environmental/stress stimuli and infectious agents. There is increasing evidence to suggest that IL-15 may play an important role in protective immune responses, allograft rejection and the pathogenesis of autoimmune diseases, where mononuclear cell infiltration is a hallmark feature. Herein, the effects of IL-15 on cells associated with host defense, immunity and inflammation are reviewed and support a central role for this cytokine in orchestrating multiple aspects of effector functions in immunity and inflammation.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Agostini C., Trentin L., Facco M., Sancetta R., Cerutti A., Tassinari C., Cimarosto L., Adami F., Cipriani A., Zambello R. and Semenzato G. (1996): Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. J. Immunol., 157, 910–918.
Anderson D. M., Johnson L., Glaccum M. B., Copeland N. G., Gilbert D. J., Jenkins N. A., Valentine V., Kirstein M. N., Shapiro D. N., Morris S. W., Grabstein K. and Cosman D. (1995): Chromosomal assignment and genomic structure of IL-15. Genomics, 25, 701–706.
Armitage R. J., Macduff B. M., Eisenman J., Paxton R. and Grabstein K. H. (1995): IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J. Immunol., 154, 483–490.
Azimi N., Brown K., Bamford R. N., Tagaya Y., Siebenlist U. and Waldmann T. A. (1998): Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-kappaB site. Proc. Natl. Acad. Sci. USA, 95, 2452–2457.
Baan C. C., Knoop C. J., Holweg C. T., van Gelder T., Metselaar H. J., Niesters H. G., Zondervan P. E., Balk A. H. and Weimar W. (1999): The macrophage-derived T-cell growth factor interleukin-15 is present in interleukin-2-independent rejection after clinical heart and liver transplantation. Transplant. Proc., 31, 2726–2728.
Badolato R., Ponzi A. N., Millesimo M., Notarangelo L. D. and Musso T. (1997): Interleukin-15 (IL-15) induces IL-8 and monocyte chemotactic protein 1 production in human monocytes. Blood, 90, 2804–2809.
Bamford R. N., Battiata A. P., Burton J. D., Sharma H. and Waldmann T. A. (1996): Interleukin (IL) 15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus type I region/IL-15 fusion message that lacks many upstream AUGs that normally attenuates IL-15 mRNA translation. Proc. Natl. Acad. Sci. USA, 93, 2897–2902.
Bamford R. N., Grant A. J., Burton J. D., Peters C., Kurys G., Goldman C. K., Brennan J., Roessler E. and Waldmann T. A. (1994): The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl. Acad. Sci. USA, 91, 4940–4944.
Bazan J. F. (1990): Structural design and molecular evolution of a cytokine receptor super-family. Proc. Natl. Acad. Sci. USA, 87, 6934–6938.
Bykovskaia S. N., Buffo M., Zhang H., Bunker M., Levitt M. L., Agha M., Marks S., Evans C., Ellis P., Shurin M. R. and Shogan J. (1999): The generation of human dendritic and NK cells from hemopoietic progenitors induced by interleukin-15. J. Leukoc. Biol., 66, 659–666.
Canals A., Gasbarre L. C., Boyd P. C., Almeria S. and Zarlenga D. S. (1997): Cloning and expression of bovine interleukin-15: analysis and modulation of transcription by exogenous stimulation. J. Interferon Cytokine Res., 17, 473–480.
Canals A., Grimm D. R., Gasbarre L. C., Lunney J. K. and Zarlenga D. S. (1997): Molecular cloning of cDNA encoding porcine interleukin-15. Gene, 195, 337–339.
Candotti F., O’Shea J. J. and Villa A. (1998): Severe combined immune deficiencies due to defects of the common gamma chain-JAK3 signaling pathway. Springer Semin. Immunopathol., 19, 401–415.
Cao X., Shores E. W., Hu-Li J., Anver M. R., Kelsall B. L., Russell S. M., Drago J., Noguchi M., Grinberg A., Bloom E. T., Paul W. E., Katz S. I., Love P. E. and Leonard W. J. (1995): Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity, 2, 223–238.
Carson W. E., Fehniger T. A., Haldar S., Eckhert K., Lindemann M. J., Lai C. F., Croce C. M., Baumann H. and Caligiuri M. A. (1998): A potential role for interleukin-15 in the regulation of human natural killer cell survival. Gastroenterology, 115, 1439–1445.
Carson W. E., Ross M. E., Baiocchi R. A., Marien M. J., Boiani N., Grabstein K. and Caligiuri M. A. (1995): Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. J. Clin. Invest., 96, 2578–2582.
Chehimi J., Marshall J. D., Salvucci O., Frank I., Chehimi S., Kawecki S., Bacheller D., Rifat S. and Chouaib S. (1997): IL-15 enhances immune functions during HIV infection. J. Immunol., 158, 5978–5987.
Cho B. K., Wang C., Sugawa S., Eisen H. N. and Chen J. (1999): Functional differences between memory and naive CD8 T cells. Proc. Natl. Acad. Sci. USA, 96, 2976–2981.
Choi K. D., Lillehoj H. S., Song K. D. and Han J. Y. (1999): Molecular and functional characterization of chicken IL-15. Dev. Comp. Immunol., 23, 165–177.
Chu C. L., Chen S. S., Wu T. S., Kuo S. C. and Liao N. S. (1999): Differential effects of IL-2 and IL-15 on the death and survival of activated TCR gamma delta+ intestinal intraepithelial lymphocytes. J. Immunol., 162, 1896–1903.
Kakumu S., Okumura A., Ishikawa T., Yano M., Enomoto A., Nishimura H., Yoshioka K. and Davey R. T. jr., Chaitt D. G., Albert J. M., Piscitelli S. C., Kovacs J. A., Walker R. E., Falloon J., Polis M. A., Metcalf J. A., Masur H., Dewar R., Baseler M., Fyfe G., Giedlin M. A. and Lane H. C. (1999): A randomized trial of high-versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection. J. Infect. Dis., 179, 849–858.
Davis I. D. (1998): Cytokine therapy in metastatic renal cancer. N. Engl. J. Med., 339, 850–851.
Dirksen U., Asadi-Moghaddam K., Fuhrer M. and Burdach S. (1998): Defunct hematopoietic progenitor growth and heterogeneous immunological phenotypes in acquired aplastic anemia of childhood: identification of subsets with decreased hematopoietic progenitors and increased IL15 or IL10 production. Klin. Padiatr., 210, 167–172.
Di Santo J. P., Colucci F. and Guy-Grand D. (1998): Natural killer and T cells of innate and adaptive immunity: lymphoid compartments with different requirements for common gamma chain-dependent cytokines. Immunol. Rev., 165, 29–38.
Doherty T. M., Seder R. A. and Sher A. (1996): Induction and regulation of IL-15 expression in murine macrophages. J. Immunol., 156, 735–741.
Ebert E. C. (1998): Interleukin 15 is a potent stimulant of intraepithelial lymphocytes. Gastroenterology, 115, 1439–1445.
Fawaz L. M., Sharif-Askari E. and Menezes J. (1999): Up-regulation of NK cytotoxic activi- ty via IL-15 induction by different viruses: a comparative study. J. Immunol., 163, 4473–4480.
Giri J. G., Anderson D. M., Kumaki S., Park L. S., Grabstein K. H. and Cosman D. (1995a): IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2. J. Leukoc. Biol., 57, 763–766.
Giri J. G., Kumaki S., Ahdieh M., Friend D. J., Loomis A., Shanebeck K., DuBose R., Cosman D., Park L. S. and Anderson D. M. (1995b): Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO J., 14, 3654–3663.
Grabstein K. H., Eisenman J., Shanebeck K., Rauch C., Srinivasan S., Fung V., Beers C., Richardson J., Schoenborn M. A., Ahdieh M., Johnson L., Alderson M. R., Watson J. D., Anderson D. M. and Giri J. G. (1994): Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science, 264, 965–968.
Hirose K., Nishimura H., Matsuguchi T. and Yoshikai Y. (1999): Endogenous IL-15 might be responsible for early protection by natural killer cells against infection with an avirulent strain of Salmonella choleraesuis in mice. J. Leukoc. Biol., 66, 382–390.
Hirose K., Suzuki H., Nishimura H., Mitani A., Washizu J., Matsuguchi T. and Yoshikai Y. (1998): Interleukin-15 may be responsible for early activation of intestinal intraepithelial lymphocytes after oral infection with Listeria monocytogenes in rats. Infect. Immun., 66, 5677–5683.
Johnston J. A., Bacon C. M., Riedy M. C. and O’Shea J. J. (1996): Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency. J. Leukoc. Biol., 60, 441–452.
Kacani L., Stoiber H. and Dierich M. P. (1997): Role of IL-15 in HIV-1-associated hypergammaglobulinaemia. Clin. Exp. Immunol., 108, 14–18.
Yoshika Y. (1997): Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease. Clin. Exp. Immunol., 109, 458–463.
Kennedy M. K., Glaccum M., Brown S. N., Butz E. A., Viney J. L., Embers M., Matsuki N., Charrier K., Sedger L., Willis C. R., Brasel K., Mirrissey P. J., Stocking K., Schuh J. C., Joyce S. and Peschon J. J. (2000): Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med., 191, 771–780.
Kennedy M. K., Park L. S. and Paxton R. J. (1998): Interleukin-15. In Thomson A. (ed.): The cytokine handbook, 3rd ed. Academic Press, San Diego, California, USA, 443–464.
Kirman I., Vainer B. and Nielsen O. H. (1998): Interleukin-15 and its role in chronic inflammatory diseases. Inflamm. Res., 47, 285–289.
Kuniyoshi J. S., Kuniyoshi C. J., Lim A. M., Wang F. Y., Bade E. R., Lau R., Thomas E. K. and Weber J. S. (1999): Dendritic cell secretion of IL-15 is induced by recombinant huCD40LT and augments the stimulation of antigen-specific cytolytic T cells. Cell. Immunol., 193, 48–58.
Lauw F. N., Simpson A. J., Prins J. M., Smith M. D., Kurimoto M., van Deventer S. J., Speelman P., Chaowagul W., White N. J. and van der Poll T. (1999): Elevated plasma concentrations of interferon (IFN)-gamma and the IFN-gamma-inducing cytokines interleukin (IL)-18, IL-12, and IL-15 in severe melioidosis. J. Infect. Dis., 180, 1878–1885.
Lodolce J. P., Boone D. L., Chai S., Swain R. E., Dassopoulos T., Trettin S. and Ma A. (1998): IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity, 9, 669–676.
Luzza E, Parrello T., Monteleone G., Sebkova L., Imeneo M., La Vecchia A., Maletta M., Docimo C. and Pallone E (1999): Changes in the mucosal expression of interleukin 15 in Helicobacter pylori-associated gastritis. FEMS Immunol. Med. Microbiol., 24, 233–238.
Maeurer M., Seliger B., Trinder P., Gerdes J. and Seitzer U. (1999): Interleukin-15 in mycobacterial infection of antigen-presenting cells. Scand. J. Immunol., 50, 280–288.
McInnes I. B. and Liew F. Y. (1998): Interleukin 15: a proinflammatory role in rheumatoid arthritis synovitis. Immunol. Today, 19, 75–79.
Meazza R., Verdiani S., Biassoni R., Coppolecchia M., Gaggero A., Orengo A. M., Colombo M. P., Azzarone B. and Ferrini S. (1996): Identification of a novel interleukin-15 (IL-15) transcript isoform generated by alternative splicing in human small cell lung cancer cell lines. Oncogene, 12, 2187–2192.
Mody C. H., Spurrell J. C. and Wood C. J. (1998): Interleukin-15 induces antimicrobial activity after release by Cryptococcus neoformans-stimulated monocytes. J. Infect. Dis., 178, 803–814.
Mrozek E., Anderson P. and Caligiuri M. A. (1996): Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood, 87, 2632–2640.
Musso T., Calosso L., Zucca M., Millesimo M., Puliti M., Bulfone-Paus S., Merlino C., Savoia D., Cavallo R., Ponzi A. N. and Badolato R. (1998): Interleukin-15 activates proinflammatory and antimicrobial functions in polymorphonuclear cells. Infect. Immun., 66, 2640–2647.
Musso T., Calosso L., Zucca M., Millesimo M., Ravarino D., Giovarelli M., Malavasi E, Ponzi A. N., Paus R. and Bulfone-Paus S. (1999): Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15. Blood, 93, 3531–3539.
Nishimura H., Yajima T., Naiki Y., Tsunobuchi H., Umemura M., Itano K., Matsuguchi T., Suzuki M., Ohashi P. S. and Yoshikai Y. (2000): Differential roles of interleukin 15 mRNA isoforms generated by alternative splicing in immune responses in vivo. J. Exp. Med., 191, 157–170.
Ogasawara K., Hida S., Azimi N., Tagaya Y., Sato T., Yokochi-Fukuda T., Waldmann T. A., Taniguchi T. and Taki S. (1998): Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature, 391, 700–703.
Ohteki T., Yoshida H., Matsuyama T., Duncan G. S., Mak T. W. and Ohashi P. S. (1998): The transcription factor interferon regulatory factor 1 (IRF-1) is important during the maturation of natural killer 1.1+ T cell receptor-alpha/beta+ (NK1+ T) cells, natural killer cells, and intestinal intraepithelial T cells. J. Exp. Med., 187, 967–972.
Onu A., Pohl T., Krause H. and Bulfone-Paus S. (1997): Regulation of IL-15 secretion via the leader peptide of two IL-15 isoforms. J. Immunol., 158, 255–262.
Oppenheimer-Marks N., Brezinschek R. I., Mohamadzadeh M., Vita R. and Lipsky P. E. (1998): Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells in vitro and in the SCID mouse-human rheumatoid arthritis model in vivo. J. Clin. Invest., 101, 1261–1272.
Park Y. B., Kim D. S., Lee W. K., Suh C. H. and Lee S. K. (1999): Elevated serum interleukin-15 levels in systemic lupus erythematosus. Yonsei. Med. J., 40, 343–348.
Pashenkov M., Mustafa M., Kivisakk P. and Link H. (1999): Levels of interleukin-l5-expressing blood mononuclear cells are elevated in multiple sclerosis. Scand. J. Immunol., 50, 302–308.
Pavlakis M., Strehlau J., Lipman M., Shapiro M., Maslinski W. and Strom T. B. (1996): Intragraft IL-15 transcripts are increased in human renal allograft rejection. Transplantation, 62, 543–545.
Perera L. P., Goldman C. K. and Waldmann T. A. (1999): IL-15 induces the expression of chemokines and their receptors in T lymphocytes. J. Immunol., 162, 2606–2612.
Reinecker H. C., MacDermott R. P., Mirau S., Dignass A. and Podolsky D. K. (1996): Intestinal epithelial cells both express and respond to interleukin 15. Gastroenterology, 111, 1706–1713.
Ruchatz H., Leung B. P., Wei X. Q., McInnes I. B. and Liew F. Y. (1998): Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology. J. Immunol., 160, 5654–5660.
Sancho D., Yanez-Mo M., Tejedor R. and Sanchez-Madrid F. (1999): Activation of peripheral blood T cells by interaction and migration through endothelium: role of lymphocyte function antigen- 1/intercellular adhesion molecule-1 and interleukin-15. Blood, 93, 886–896.
Sinkovics J. G. and Horvath J. C. (2000): Vaccination against human cancers. Int. J. Oncol., 16, 81–96.
Sprent J., Zhang X., Sun S. and Tough D. (1999): T-cell turnover in vivo and the role of cytokines. Immunol. Lett., 65, 21–25.
Tagaya Y., Burton J. D., Miyamoto Y. and Waldmann T. A. (1996): Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells. EMBO J., 16, 4928–4939.
Tagaya Y., Kurys G., Thies T. A., Losi J. M., Azimi N., Hanover J. A., Bamford R. N. and Waldmann T. A. (1997): Generation of secretable and nonsecretable interleukin 15 isoforms through alternate usage of signal peptides. Proc. Natl. Acad. Sci. USA, 94, 14444–14449.
Vazquez N., Walsh T. J., Friedman D., Chanock S. J. and Lyman C. A. (1998): Interleukin-15 augments superoxide production and microbicidal activity of human monocytes against Candida albicans. Infect. Immun., 66, 145–150.
Winger F., Brar S. S., Mayne A., Chikkala N. and Ansari A. A. (1995): Comparative sequence analysis of cytokine genes from human and nonhuman primates. J. Immunol., 155, 3946–3954.
Waldmann T. A. and Tagaya Y. (1999): The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu. Rev. Immunol., 17, 19–49.
Warren H. S. (1996): NK cell proliferation and inflammation. Immunol. Cell. Biol., 74, 473–480.
Washizu J., Nishimura H., Nakamura N., Nimura Y. and Yoshikai Y. (1998): The NF-kappa B binding site is essential for transcriptional activation of the IL-15 gene. Immunogenetics, 48, 1–7.
Williams N. S., Klem J., Puzanov I. J., Sivakumar P. V., Schatzle J. D., Bennett M. and Kumar V. (1998): Natural killer cell differentiation: insights from knockout and transgenic mouse models and in vitro systems. Immunol. Rev., 165, 47–61.
Yamada Y. and Kamihira S. (1999): Pathological roles of interleukin-15 in adult T-cell leukemia. Leuk. Lymphoma, 35, 37–45.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Perera, L.P. (2001). Interleukin 15: Its Role in Inflammation and Immunity. In: Górski, A., Krotkiewski, H., Zimecki, M. (eds) Inflammation. Springer, Dordrecht. https://doi.org/10.1007/978-94-015-9702-9_4
Download citation
DOI: https://doi.org/10.1007/978-94-015-9702-9_4
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-5852-2
Online ISBN: 978-94-015-9702-9
eBook Packages: Springer Book Archive